Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fratelli, M
Right arrow Articles by Ghezzi, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fratelli, M
Right arrow Articles by Ghezzi, P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells

M Fratelli, V Gagliardini, G Galli, P Gnocchi, P Ghiara and P Ghezzi

Istituto di Richerche Farmacologiche Mario Negri, Milan, Italy.

We demonstrate here that EL4-6.1 cells, a mouse thymoma that expresses high levels of membrane interleukin (IL)-1 receptors, produce IL-1 beta as an autocrine regulatory factor. Endogenous IL-1 beta sustains both proliferation and apoptosis: during the exponential phase, it mainly promotes proliferation, while during the plateau phase of cell growth, it induces death by apoptosis. Additionally, we show that exogenous IL- 1 beta added to EL4-6.1 cells in lag phase induces apoptosis in a portion of the cells and proliferation in the remaining cells. Therefore, IL-1 beta can exert two completely opposite effects on a single cell type, depending on the state of the target cell.

Volume 85, Issue 12, pp. 3532-3537, 06/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
J. Forssell, A. Oberg, M. L. Henriksson, R. Stenling, A. Jung, and R. Palmqvist
High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon Cancer
Clin. Cancer Res., March 1, 2007; 13(5): 1472 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. T. Costello, F. Mallet, B. Gaugler, D. Sainty, C. Arnoulet, J.-A. Gastaut, and D. Olive
Human Acute Myeloid Leukemia CD34+/CD38- Progenitor Cells Have Decreased Sensitivity to Chemotherapy and Fas-induced Apoptosis, Reduced Immunogenicity, and Impaired Dendritic Cell Transformation Capacities
Cancer Res., August 1, 2000; 60(16): 4403 - 4411.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Zen, A. Karsan, A. Stempien-Otero, E. Yee, J. Tupper, X. Li, T. Eunson, M. A. Kay, C. B. Wilson, R. K. Winn, et al.
NF-kappa B Activation Is Required for Human Endothelial Survival during Exposure to Tumor Necrosis Factor-alpha but Not to Interleukin-1beta or Lipopolysaccharide
J. Biol. Chem., October 1, 1999; 274(40): 28808 - 28815.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020